4.6 Review

Cellular signaling perturbation by natural products

Journal

CELLULAR SIGNALLING
Volume 21, Issue 11, Pages 1541-1547

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cellsig.2009.03.009

Keywords

Cell signaling; Cancer; Natural products

Categories

Funding

  1. NCI NIH HHS [5R01CA108535, R01 CA083695-07, 5R01CA083695, R01 CA131151-02, R01 CA101870, R01 CA132794, R01 CA131151, R01 CA083695, R01 CA108535, R01 CA131151-02S1, 5R01CA101870, R01 CA132794-01A1, R01 CA101870-05] Funding Source: Medline

Ask authors/readers for more resources

Cancer cells are known to have alterations in multiple cellular signaling pathways and because of the complexities in the communication between multiple signaling networks, the treatment and the cure for most human malignancies is still an open question. Perhaps, this is the reason why specific inhibitors that target only one pathway have been typically failed in cancer treatment. However, the in vitro and in vivo studies have demonstrated that some natural products such as isoflavones, indole-3-carbinol (13C), 3,3'-diindolylmethane (DIM), curcumin, (-)-epigallocatechin-3-gallate (EGCG), resveratrol, lycopene, etc, have inhibitory effects on human and animal cancers through targeting multiple cellular signaling pathways and thus these natural agents could be classified as multi-targeted agents. This is also consistent with the epidemiological studies showing that the consumption of fruits, soybean and vegetables is associated with reduced risk of several types of cancers. By regulating multiple important cellular signaling pathways including NF-kappa B, Akt, MAPK, Wnt, Notch, p53, AR, ER, etc, these natural products are known to activate cell death signals and induce apoptosis in pre-cancerous or cancer cells without affecting normal cells. Therefore, non-toxic natural agents harvested from the bounties of nature could be useful either alone or in combination with conventional therapeutics for the prevention of tumor progression and/or treatment of human malignancies. (C) 2009 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available